All companies › NXTC

NXTC · NextCure, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys3
Open-market sells0
Total purchased$53,691
Unique insiders buying1
Avg price paid$4.95
Research cases0
Last filing2026-10-27

Average price paid is weighted by shares, so a large purchase counts for more than a small one. It is what insiders reported paying, not a target or a fair value.

Insider flow: Buying only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-10-23 — ADAR1 Capital Management, LLC · bought 5,626 @ $4.83 2026-10-26 — ADAR1 Capital Management, LLC · bought 1,672 @ $5.03 2026-10-27 — ADAR1 Capital Management, LLC · bought 3,553 @ $5.10
2026-10-232026-10-27

Insider cost basis

Share-weighted average price across 3 reported purchases, with the full range of prices paid. Purchases only — averaging a sale into an "insider cost" would describe a price nobody paid.

$4.83 $5.10
$4.95 weighted average insider purchase price

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

ADAR1 Capital Management, LLC 10% owner
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $NXTC is the reading of them — and for this company, that is what the list below says it is, no more.

  • Insider cost basisShare-weighted average price paid across the 3 reported purchases, with the full range, against the current price.
  • Insider participationWho bought, how often, and how the buying is distributed across the people filing — one person repeating is not several agreeing.
  • Transaction timelineThe [{'transaction_date': '2026-10-27', 'insider_name': 'ADAR1 Capital Management, LLC', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 3553.0, 'price': 5.0953, 'value': 18103.6, 'is_buy': True}, {'transaction_date': '2026-10-26', 'insider_name': 'ADAR1 Capital Management, LLC', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 1672.0, 'price': 5.0344, 'value': 8417.52, 'is_buy': True}, {'transaction_date': '2026-10-23', 'insider_name': 'ADAR1 Capital Management, LLC', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 5626.0, 'price': 4.8294, 'value': 27170.2, 'is_buy': True}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for NXTC today: no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.